HCAT

Health Catalyst, Inc (HCAT)
Healthcare • Health Information Services • $1.69 • MCap: 127,183,296 🌐
https://www.healthcatalyst.com • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Buy Decision Core
Total Score
31
Business Quality
10
Financial Strength
4
Growth Outlook
1
Momentum
0
Price Action
Current
1.69
52W High
3.46
52W Low
1.00
Above 50DMA
1.96 (-13.92%)
Above 200DMA
1.86 (-9.09%)
Relative Strength
Relative Strength
-0.25
RS 3M
-0.12
RS 6M
-0.13
RS 9M
-0.38
RS 12M
-0.5
Fundamentals
Revenue Growth
-0.13%
Earnings Growth
0%
ROE
-1.18%
ROA
-0.03%
Valuation
PE (Fwd)
215.29
PEG
0
P/B
1.25
Upside
7.99%
Risk
Beta
1.53
Short %
0.04
Risk Score
7.00
Analyst
Rating
hold
Target
1.82
Beta
1.53
Analysts
0


Total Score
31
Upside
7.99%
Relative Strength
-0.25
Beta
1.53
Why Buy?
  • PEG Ratio below 1 (attractive valuation)
Key Risks
  • Revenue growth is negative
  • Negative ROE
  • High volatility (Beta > 1.5)
  • Weak long-term relative strength
Score Breakdown
Business
10
Financial
4
Growth
1
Valuation
10
Risk
3
Momentum
0
Technical
52W High: 3.46
52W Low: 1.00
Above 50DMA: -13.92%
Above 200DMA: -9.09%
Valuation
Forward PE: 215.29
PEG: 0
P/B: 1.25
Upside: 7.99%
Risk
Beta: 1.53
Short Float: 0.04%
ROE: -1.18%
ROA: -0.03%